Physician profile
Anil Sharma
NPI 1730137878
$1,266.76
in general payments reported to CMS, 2019-2025
13 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.35 · 2020: $145 · 2021: $83.63 · 2022: $174 · 2023: $290 · 2024: $343 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $311.65 | 2020-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $188.73 | 2024-2025 | Sprint Pns System |
| Intercept Pharmaceuticals, INC. | $128.84 | 2019-2023 | Ocaliva |
| Becton, Dickinson and Company | $120.81 | 2024 | Phasix Mesh |
| Medtronic, INC. | $120.37 | 2023 | Intellis Adaptivestim |
| Si-Bone, INC. | $115.66 | 2020 | |
| Stryker Corporation | $110.34 | 2023 | Vitoss |
| Collegium Pharmaceutical, INC. | $46.46 | 2024 | Xtampza |
| Daiichi Sankyo INC. | $41.46 | 2019-2021 | |
| Celgene Corporation | $35.12 | 2021-2022 | |
| Boston Scientific Corporation | $26.37 | 2022 | |
| Vertos Medical, INC. | $20.95 | 2023 | Mild Device Kit |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.